Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIOP CNS GCT II for Intracranial Germ Cell Tumors
NCT01424839Phase 4Unknown
- Sponsor
- Universitätsklinikum Münster
- Start
- Oct 2011
- Primary completion
- Oct 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of carboplatin, cisplatin, etoposide, ifosfamide in intracranial germ cell tumor (ICGCT), sponsored by Universitätsklinikum Münster. Status: unknown.
02
Drugs
carboplatincisplatinetoposideifosfamide
03
Conditions
intracranial germ cell tumor (ICGCT)
Beyond the preview
Go deeper on NCT01424839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01424839.